PatientsLikeMe touts the results of a patient-initiated ALS-treatment study that indicates the benefits of social networking in clinical trials.
Social networking may someday become a part of clincal trials on medical devices and drugs.
A recent trial found that lithium carbonate didn't slow the progression of Lou Gehrig's disease, or amyotrophic lateral sclerosis (ALS), but the study also indicated that the use of a social network to enroll patients and report and collect data could facilitate future studies.
InspireMD presents new 6 month follow-up data showing better survival rates for its MGuard stent
Symbios Medical Products recalls 2 years' worth of its GoPump systems and GOBlock kits after...
Covidien's MicroStream MicroPod respiratory monitoring module hits the shelves
The newly unveiled iteration of the Microsoft Xbox One's Kinect camera demonstrates the ability to...
If you read nothing else today, make sure you're still in the know with MassDevice +3.